These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35746542)

  • 1. Efficacy of a Modified Live Porcine Reproductive and Respiratory Syndrome Virus 1 (PRRSV-1) Vaccine against Experimental Infection with PRRSV AUT15-33 in Weaned Piglets.
    Duerlinger S; Knecht C; Sawyer S; Balka G; Zaruba M; Ruemenapf T; Kraft C; Rathkjen PH; Ladinig A
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a Modified Live Virus Vaccine against Porcine Reproductive and Respiratory Syndrome Virus 1 (PRRSV-1) Administered to 1-Day-Old Piglets in Front of Heterologous PRRSV-1 Challenge.
    Kreutzmann H; Dürlinger S; Knecht C; Koch M; Cabana M; Torrent G; Balasch M; Taylor LP; Balka G; Gerner W; Ladinig A
    Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
    Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production results from piglets vaccinated in a field study in Spain with a Type 1 Porcine Respiratory and Reproductive virus modified live vaccine.
    Cano G; Cavalcanti MO; Orveillon FX; Kroll J; Gomez-Duran O; Morillo A; Kraft C
    Porcine Health Manag; 2016; 2():22. PubMed ID: 28405448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic Characterization of a Virulent PRRSV-1 Isolate in a Reproductive Model With and Without Prior Heterologous Modified Live PRRSV-1 Vaccination.
    Kreutzmann H; Stadler J; Knecht C; Sassu EL; Ruczizka U; Zablotski Y; Vatzia E; Balka G; Zaruba M; Chen HW; Riedel C; Rümenapf T; Ladinig A
    Front Vet Sci; 2022; 9():820233. PubMed ID: 35464363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of PRRSv specific, maternally derived and induced immune response in Ingelvac PRRSFLEX EU vaccinated piglets in the presence of maternally transferred immunity.
    Kraft C; Hennies R; Dreckmann K; Noguera M; Rathkjen PH; Gassel M; Gereke M
    PLoS One; 2019; 14(10):e0223060. PubMed ID: 31577832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
    Park C; Seo HW; Han K; Kang I; Chae C
    Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions.
    Rose N; Renson P; Andraud M; Paboeuf F; Le Potier MF; Bourry O
    Vaccine; 2015 May; 33(21):2493-9. PubMed ID: 25820061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
    Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
    Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.
    Sattler T; Pikalo J; Wodak E; Revilla-Fernández S; Steinrigl A; Bagó Z; Entenfellner F; Claude JB; Pez F; Francillette M; Schmoll F
    BMC Vet Res; 2018 Apr; 14(1):133. PubMed ID: 29673363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of 1-day-old pigs with a porcine reproductive and respiratory syndrome virus (PRRSV) modified live attenuated virus vaccine is able to overcome maternal immunity.
    Balasch M; Fort M; Taylor LP; Calvert JG
    Porcine Health Manag; 2018; 4():25. PubMed ID: 30459958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
    Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
    Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
    Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
    Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Characteristics and Pathogenicity of a Novel Recombinant Porcine Reproductive and Respiratory Syndrome Virus Strain from NADC30-, NADC34-, and JXA1-Like Strains That Emerged in China.
    Liu J; Liu C; Xu Y; Yang Y; Li J; Dai A; Huang C; Luo M; Wei C
    Microbiol Spectr; 2022 Dec; 10(6):e0266722. PubMed ID: 36354339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
    Renson P; Fablet C; Andraud M; Normand V; Lebret A; Paboeuf F; Rose N; Bourry O
    Vaccine; 2019 Jul; 37(31):4318-4324. PubMed ID: 31248683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.
    Yu X; Zhou Z; Cao Z; Wu J; Zhang Z; Xu B; Wang C; Hu D; Deng X; Han W; Gu X; Zhang S; Li X; Wang B; Zhai X; Tian K
    Clin Vaccine Immunol; 2015 May; 22(5):493-502. PubMed ID: 25739919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.